Synthetic peptide, corresponding to C terminal amino acids 397-411 of Human WWOX1
Our Abpromise guarantee covers the use of ab14691 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use at an assay dependent concentration. Predicted molecular weight: 46 kDa.|
|IHC-Fr||Use at an assay dependent concentration.|
ab14691 has not yet been referenced specifically in any publications.